Skip to main content

Find Clinical Trials

Home
Conditions
Nausea

Clinical trial condition

Nausea

Explore clinical trials studying Nausea. Study availability and eligibility vary by location and protocol.

450 public trials 46 recruiting studies

Refine in advanced search Browse all conditions

Nausea trial results

Completed

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

NCT00253708

Conditions: Adenocarcinoma, Adnexal Diseases, Behavior, +77 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer

NCT00440128

Conditions: Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pathological Conditions, Signs and Symptoms, +3 more
Locations: GSK Investigational Site Hot Springs, Arkansas, United States

GSK Investigational Site Iowa City, Iowa, United States

GSK Investigational Site Detroit, Michigan, United States

GSK Investigational Site Lebanon, New Hampshire, United States

View Trial Details

Completed

A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults

NCT00460707

Conditions: Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pathological Conditions, Signs and Symptoms, +3 more
Locations: GSK Investigational Site Overland Park, Kansas, United States

GSK Investigational Site Buffalo, New York, United States

GSK Investigational Site Columbus, Ohio, United States

View Trial Details

Completed

The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects

NCT00511823

Conditions: Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pathological Conditions, Signs and Symptoms, +3 more
Locations: GSK Investigational Site Evansville, Indiana, United States

View Trial Details

Completed

Optimal Dose of Prophylactic Naloxone in Reducing Opioid-Induced Side Effects in Children/Adolescents

NCT00330343

Conditions: Nausea, Neurologic Manifestations, Pain, +7 more
Locations: John Hopkins Hospital Baltimore, Maryland, United States

View Trial Details

Completed

Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer

NCT00343863

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +14 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX

NCT00381862

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +17 more
Locations: St. Josephs/Cander Hospital Savannah, Georgia, United States

Kaiser Permanente Hilo, Hawaii, United States

Ingalls Memorial Hospital Harvey, Illinois, United States

Kansas City Cancer Center Kansas City, Missouri, United States

View Trial Details

Completed

Auricular Acupressure for Chemotherapy-Induced Nausea and Vomiting in Female Breast Cancer Patients

NCT02403037

Conditions: Breast Diseases, Breast Neoplasms, Nausea, +8 more
Locations: The Second People's Hospital of Fujian Province Fuzhou, Fujian, China

The First People's Hospital of Fujian Province Fuzhou, Fujian, China

Fujian Provincial Cancer Hospital Fuzhou, Fujian, China

View Trial Details

Completed

Study of the Effect of Intramuscular Ephedrine on the Incidence of Nausea and Vomiting During Elective Cesarean Section

NCT00432991

Conditions: Cesarean Section, Nausea, Pathological Conditions, Signs and Symptoms, +3 more
Locations: New York-Presbyterian Hospital; Weill Medical College of Cornell New York, United States

View Trial Details

Completed

Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)

NCT00684463

Conditions: Nausea, Neoplasms, Pathological Conditions, Signs and Symptoms, +3 more
Locations: Not specified

View Trial Details